Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,064 signal articles · 240 in last 24h · 119,541 total before filter · latest 31m ago
240last 24h
1474last 7d
251● bullish (7d)
157● bearish (7d)
205publishers
AllMacro282Earnings562M&A105Regulatory20Product13Analyst22
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is Oscar Health (OSCR) Undervalued After Its Earnings Beat And Guidance Raise?
Simply Wall St.4d agobullish
Is Oscar Health (OSCR) Undervalued After Its Earnings Beat And Guidance Raise?

Oscar Health (OSCR) is back in focus after reporting second quarter 2026 results that swung from a loss to net income of $361.81 million and raising full year earnings guidance. See our latest analysis for Oscar Health. Oscar Health shares have been volatile around the earnings release, with an 11.9% drop reported after the outlook update. The stock still shows a 118.84% year to date share price return and a 109.46% 1 year total shareholder return, suggesting momentum remains strong despite...

Bill Ackman makes a bold move to answer investors biggest wish
TheStreet4d agoneutral
Bill Ackman makes a bold move to answer investors biggest wish

One of the most common frustrations I hear from everyday investors goes something like this: "I knew SpaceX was going to be huge. I just never got the chance to invest before the IPO." Bill Ackman heard the same thing and decided to do something. The billionaire hedge fund manager put it plainly on ...

Is MongoDB (MDB) Getting Too Rich For Its AI Promise?
Simply Wall St.4d agoneutral
Is MongoDB (MDB) Getting Too Rich For Its AI Promise?

MongoDB stock has delivered a very strong 110.9% return over the past year, yet the valuation checks currently lean expensive rather than pointing to a clear bargain. Over the last 12 months MongoDB has returned 110.9%, which puts extra focus on whether the current price already reflects high expectations. Recent product news around AI focused capabilities such as the Atlas Managed MCP Server and retrieval models can support optimistic growth assumptions, while any disappointment in how...

Can Oscar Health (OSCR) Still Look Cheap After Strong Q2?
Simply Wall St.4d agoneutral
Can Oscar Health (OSCR) Still Look Cheap After Strong Q2?

Oscar Health stock has delivered a very large 3 year return while the broader valuation checks still lean cautious, with a low value score hinting that the recent re rating may not be a simple bargain story. Oscar Health has returned about 3.6x over the past 3 years, which puts a spotlight on whether recent enthusiasm already prices in much of the progress. Recent profitability and revenue growth can support investor expectations for the business, while concerns around medical cost trends...

Jim Cramer reveals 6 AI stocks to watch in 2026
TheStreet4d agoneutral
Jim Cramer reveals 6 AI stocks to watch in 2026

For most of the summer, investors pulled money out of chipmakers and data center names and moved it into health care, banks, and retailers. The AI infrastructure trade led the market for two years. This summer, it underperformed. Jim Cramer says that phase is over. On CNBC's "Mad Money," the ...

Mastercard vs. Visa: One Fintech Giant Has the Stronger Growth Story
24/7 Wall St.4d agoneutral
Mastercard vs. Visa: One Fintech Giant Has the Stronger Growth Story

Visa just crossed $4 trillion in quarterly payments volume while Mastercard keeps quietly expanding its margins and winning high-profile clients. Both giants reported earnings days apart, and the gap between their growth stories is wider than the headlines suggest.